Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study

The NTM-001 Phase I clinical study is expected to be completed by the end of 2022

Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program

Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.

Dabur launches 'Dabur Himalayan Shilajit'

Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin

Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.

Syngene reports revenue from operations up 8% in Q1 FY 23

Company raises the annual revenue guidance from mid-teens to high teens

GSK’s Haleon begins trading in LSE

Completion of the demerger of Haleon and share consolidation of GSK

Biotium introduces new line of antibodies for exosome detection

ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD

Manish led SeQuent since 2014 and played a major role in transforming the company

Think twice even before you start thinking on smoking!

Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs

Enveric Biosciences advances drug development for mental health indications

Advancing to IND-enabling studies with multiple drug candidates